On ECHEMI
Home > Drugs > Shanxi C&Y Pharmaceutical Group Co., Ltd.
Shanxi C&Y Pharmaceutical Group Co., Ltd.
  • Founded in:

    2005-03-23
  • Country:

    China China
  • Address:

    Area A, No. 1378 Heng'an Street, Datong Economic and Technological Development Zone, Shanxi Province
  • Tax NO.:

    91140200770127753X
  • Registered Funds:

    248.318563 yuan
  • Website:

  • Email:

Related Drugs
Compound bismuth subgallate suppository
This product is a compound preparation. Each tablet contains 200 mg of bismuth subgallate, 0.03 ml of belladonna fluid extract, and 0.4 mg of epinephrine.
Name Description Content CAS NO. Registered Holders
BISMUTH SUBGALLATE

Astringent and hemostatic effect

More

Astringent and hemostatic effect

200mg 99-26-3 3
Extract Belladonna soft liquid and powder

Antispasmodic and analgesic effects

More

Antispasmodic and analgesic effects

0.03ml 0
L(-)-Epinephrine

Vasoconstriction and hemostasis

More

Vasoconstriction and hemostasis

0.4mg 51-43-4 30
Erythromycin Ethylsuccinate Granules
Erythromycin ethylsuccinate.
Name Description Content CAS NO. Registered Holders
Erythromycin ethylsuccinate

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

More

This product belongs to the macrolide antibiotics, which is the ethyl succinate of erythromycin. It is more stable than erythromycin in gastric acid. It has antibacterial activity against Staphylococcus (except methicillin-resistant strains), various groups of streptococci and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. are also sensitive to this product. This product also has antibacterial effects on various anaerobic bacteria except Bacteroides fragilis and Fusobacterium. It also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can penetrate the bacterial cell membrane and form a reversible bond with the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) from binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis.

1264-62-6 25
Compound Licorice Tablets
This product is a compound preparation, and its components are: each tablet contains 112.5mg of licorice extract powder, 4mg of opium powder, 2mg of camphor, 2mg of star anise oil, and 2mg of sodium benzoate. The excipients are: mannitol, β-cyclodextrin, aspartame, polyvinyl pyrrolidone (PVP), talc, menthol, peppermint oil, and ethanol.
Name Description Content CAS NO. Registered Holders
Glycyrrhinic acid

Antitussive and expectorant, antibacterial and anti-inflammatory

More

Antitussive and expectorant, antibacterial and anti-inflammatory

112.5mg 0
Opiate powder

Inhibits the medullary cough center and suppresses cough

More

Inhibits the medullary cough center and suppresses cough

4mg 0
D-CAMPHOR

Stimulates bronchial mucus secretion, making sputum thinner and easier to cough up

More

Stimulates bronchial mucus secretion, making sputum thinner and easier to cough up

2mg 464-49-3 1
Anise Oil

Stimulates bronchial mucus secretion, making sputum thinner and easier to cough up

More

Stimulates bronchial mucus secretion, making sputum thinner and easier to cough up

2mg 84775-42-8 13
Sodium benzoate

Anti-corrosion

More

Anti-corrosion

2mg 532-32-1 23
Sertraline Hydrochloride Tablets
The main ingredient of this product is sertraline hydrochloride. Its chemical name is: (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthylamine hydrochloride.
Name Description Content CAS NO. Registered Holders
Sertraline hydrochloride

A selective serotonin reuptake inhibitor that works by inhibiting the reuptake of serotonin in central neurons, has only a weak effect on norepinephrine and dopamine, and has no obvious affinity for a variety of other receptors.

More

A selective serotonin reuptake inhibitor that works by inhibiting the reuptake of serotonin in central neurons, has only a weak effect on norepinephrine and dopamine, and has no obvious affinity for a variety of other receptors.

79559-97-0 52
Fluoxetine Hydrochloride Capsules
The main ingredient of this product is fluoxetine hydrochloride. Its chemical name is (±)-N-methyl-γ-[4-(trifluoromethyl)-phenoxy]-amphetamine hydrochloride.
Name Description Content CAS NO. Registered Holders
Fluoxetine hydrochloride

Selective serotonin reuptake inhibitors (SSRIs) can effectively inhibit neurons from taking up serotonin from the synaptic cleft, increase the amount of this neurotransmitter available for actual use in the cleft, thereby improving emotional states and treating depressive disorders.

More

Selective serotonin reuptake inhibitors (SSRIs) can effectively inhibit neurons from taking up serotonin from the synaptic cleft, increase the amount of this neurotransmitter available for actual use in the cleft, thereby improving emotional states and treating depressive disorders.

56296-78-7 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.